aXichem
aXichem is a Swedish specialty chemicals company that develops, patents, and markets natural-analogue industrial compounds based on phenylcapsaicin. Its commercial products are sold under the brands aXiphen® for animal feed and aXivite® for dietary supplements and bioenhancement, with operations centered in Malmö and additional presence in Bergen, Norway.
Fiscal year 2025 · change from previous year
Development 2021–2025
Business
Share of revenuePhenylcapsaicin-based products sold for poultry and other animal nutrition uses.
aXivite® ingredients used in sports, exercise, gut health, and weight management supplements.
Uses of phenylcapsaicin intended to improve efficacy or reduce dosage in formulations.
Customers
aXichem sells to distributors, formulators, and end customers in the animal nutrition and dietary supplement supply chains. Its feed business serves poultry producers and related agricultural customers, while its supplement business serves ingredient buyers in the health and wellness market, especially in the US and Europe.
Buy aXiphen® to support animal health and production outcomes in feed applications
Distribute aXiphen® into livestock and poultry channels and manage local market access
Buy aXivite® for sports nutrition, gut health, and weight management products
Resell aXivite® into supplement and functional ingredient markets
Use phenylcapsaicin-based functionality to improve formulation performance
Strategy
aXichem’s strategy centers on expanding commercial adoption of its patented phenylcapsaicin platform while continuing product and process development to support scale-up. The company also emphasizes regulatory approvals, scientific validation, and distributor-led market access in feed and dietary supplements.
The supplement business depends on market acceptance, repeat orders, and channel expansion.
Feed applications require formal approvals before broader market penetration.
Consistent large-volume production is needed to support commercial supply and margins.
Scientific validation supports customer adoption and regulatory credibility.
Geography
aXichem is headquartered in Malmö, Sweden, with additional operations in Bergen, Norway, and support from consultants in the US and Europe. Commercial activity spans Europe, the US, and parts of Asia, and the company also references product activity in Brazil through distributor-led poultry trials.
Risks
Regulatory approval and compliance are the most important company-specific risks because aXichem’s products depend on formal acceptance in feed and supplement markets. The business also faces concentration risk in a small number of products and end markets, plus execution risk tied to scale-up, distributor dependence, and international market access.
- Regulatory approval riskImpact: HighLikelihood: Medium
Products must meet safety and efficacy requirements before broad commercialization.
Exposure: Feed additive and supplement markets
- Product concentration riskImpact: High
Revenue is tied mainly to aXiphen® and aXivite®.
Exposure: Single-platform phenylcapsaicin business
- Geographic execution risk in AsiaImpact: MediumLikelihood: Low
Management notes lingering operational effects from COVID in Asia.
Exposure: Asia operations and sales
- Dilution from convertible debt and employee optionsImpact: MediumLikelihood: Low
Outstanding instruments can increase share count if exercised or converted.
Exposure: Capital structure
- Distributor dependenceImpact: Medium
Commercial reach relies on partners to access end customers and local markets.
Exposure
Accounting
Judgemental itemsDevelopment spending can build intangible assets and affect reported profit timing.
Impact: Balances in development expenses and patents
Liabilities are split into debt and equity parts using discounting and effective interest.
Impact: Interest expense and equity classification
Potential dilution depends on exercise conditions and share price.
Impact: Earnings per share and share count
Small-company structures can create non-core transactions with insiders or affiliates.
Impact: Operating expenses and disclosure quality
Similar listed companies
Publicly listed companies with a comparable business focus.
Axfood
AXFO · Consumer Staples
Axfood is a prominent player in the Swedish food retail market, operating a diverse range of grocery store concepts including Willys, Hemköp, and City Gross.
Axsome Therapeutics, Inc.
AXSM · Pharmaceutical Preparations
Axsome Therapeutics is a U.S.-based biopharmaceutical company focused on central nervous system (CNS) disorders, with a commercial portfolio built around AUVELITY, SUNOSI, and SYMBRAVO.
Axogen, Inc.
AXGN · Electromedical & Electrotherapeutic Apparatus
Annexon, Inc.
ANNX · Pharmaceutical Preparations
Axil Brands, Inc.
AXIL · Perfumes, Cosmetics & Other Toilet Preparations
Balchem Corporation
BCPC · Chemicals & Allied Products
Balchem Corp develops, manufactures, distributes, and markets specialty performance ingredients and products used in human nutrition, animal nutrition, food…
Last updated: 24/09/2026